CAFGESIC (APAP 325 MG / CAFFEINE 50 MG / PHENYLTOLOXAMINE CITRATE 20 MG / SALICYLAMIDE 250 MG) ORAL CAPSULE

Side Effects & Adverse Event Reports


View Chart Data

97.9K

Adverse Events

921.1K

Side Effects

1998

Data Starting In

SymPedia Mobile App

Get our Mobile App for easy access to the latest reports on CAFGESIC (APAP 325 MG / CAFFEINE 50 MG / PHENYLTOLOXAMINE CITRATE 20 MG / SALICYLAMIDE 250 MG) ORAL CAPSULE.

Understanding the potential Side Effects and Adverse Events of CAFGESIC (APAP 325 MG / CAFFEINE 50 MG / PHENYLTOLOXAMINE CITRATE 20 MG / SALICYLAMIDE 250 MG) ORAL CAPSULE is essential for making informed health decisions. Our application provides in-depth reports based on real-world data, helping you explore how CAFGESIC (APAP 325 MG / CAFFEINE 50 MG / PHENYLTOLOXAMINE CITRATE 20 MG / SALICYLAMIDE 250 MG) ORAL CAPSULE may affect your health.

View reports containing much more information including:

  • Age group - See how different age ranges experience side effects and adverse reactions.
  • Year - Track trends over time to understand changes in reported issues.
  • Biological sex - Compare how reports vary between men and women.
  • Weight - Examine the impact of body weight on side effects and adverse events.
Download Now

Frequently Asked Questions

Some questions about CAFGESIC (APAP 325 MG / CAFFEINE 50 MG / PHENYLTOLOXAMINE CITRATE 20 MG / SALICYLAMIDE 250 MG) ORAL CAPSULE are asked frequently. We've answered the most frequent of those questions below

  • How many adverse events have been reported for CAFGESIC (APAP 325 MG / CAFFEINE 50 MG / PHENYLTOLOXAMINE CITRATE 20 MG / SALICYLAMIDE 250 MG) ORAL CAPSULE?

    SymPedia shows CAFGESIC (APAP 325 MG / CAFFEINE 50 MG / PHENYLTOLOXAMINE CITRATE 20 MG / SALICYLAMIDE 250 MG) ORAL CAPSULE adverse event reports for 97,895.

  • How many side effects have been reported for CAFGESIC (APAP 325 MG / CAFFEINE 50 MG / PHENYLTOLOXAMINE CITRATE 20 MG / SALICYLAMIDE 250 MG) ORAL CAPSULE?

    SymPedia shows CAFGESIC (APAP 325 MG / CAFFEINE 50 MG / PHENYLTOLOXAMINE CITRATE 20 MG / SALICYLAMIDE 250 MG) ORAL CAPSULE side effect reports for 921,111.

  • What year does the CAFGESIC (APAP 325 MG / CAFFEINE 50 MG / PHENYLTOLOXAMINE CITRATE 20 MG / SALICYLAMIDE 250 MG) ORAL CAPSULE reporting data start?

    SymPedia reporting data on this page starts in 1998.

  • What years are included in the yearly chart for CAFGESIC (APAP 325 MG / CAFFEINE 50 MG / PHENYLTOLOXAMINE CITRATE 20 MG / SALICYLAMIDE 250 MG) ORAL CAPSULE?

    SymPedia yearly chart data on this page covers 1998 to 2025.